Browsing by Author "Duygu, Senay Cerezci"
Now showing 1 - 2 of 2
- Results Per Page
- Sort Options
Item Muscle skin temperature responses for hamstring and quadriceps to aerobic and anaerobic test conditions in Turkish Olympic Sailing Athletes(2019) Duygu, Senay Cerezci; Pekyavas, Nihan Ozunlu; Uzun, Ayse; Medeni, Ozge Cinar; Baltaci, Gul; Er, Fatmanur; Suveren, Ceren; Colakoglu, Filiz Fatma; 0000-0003-4060-9366; AAC-6522-2020Olympic class sailing is a competitive sport and requires several abilities. An understanding of the responses to aerobic and anaerobic loading will be useful for assessing the training programs, protective strategies and possibility of injuries. Therefore, the aim of this study is to determine lower extremity main muscles skin temperature responses to aerobic and anaerobic test conditions in Turkish Olympic Sailing Athletes. Eighteen sailing athletes were assessed during preseasonal assessment period. Temperatures of quadriceps and hamstring muscle groups were evaluated bilaterally during rest and after Wingate Treadmill tests. Wingate test was accepted as an indicator of anaerobic performance and Treadmill test as an aerobic performance. Infrared thermography was performed to assess the skin temperature at anterior and posterior parts of thigh for both legs. In the triplicate comparison, the temperature changes between the rest, aerobic test and anaerobic test conditions were significant (p<0.05). In the analysis to determine the difference between the compared groups; for both muscle groups, temperature change after anaerobic performance was not significant; in contrast to this result the change in muscle temperature after aerobic performance was significant (p<0.05). Energeticmetabolic activity of major muscle groups of lower extremities during aerobic and anaerobic performance are important for injury prevention, treatment, rehabilitation and return to play. Present study shows that aerobic performance or activities requires higher energetic-metabolic activity.Item Targeted Treatment Protocol in Patellofemoral Pain: Does Treatment Designed According to Subgroups Improve Clinical Outcomes in Patients Unresponsive to Multimodal Treatment?(2019) Yosmaoglu, Hayri Baran; Selfe, James; Sonmezer, Emel; Sahin, Ilknur Ezgi; Duygu, Senay Cerezci; Ozkoslu, Manolya Acar; Richards, Jim; Jenssen, Jessica; 31750786; AAA-4826-2020Background: Targeted intervention for subgroups is a promising approach for the management of patellofemoral pain. Hypothesis: Treatment designed according to subgroups will improve clinical outcomes in patients unresponsive to multimodal treatment. Study Design: Prospective crossover intervention. Methods: Patients with patellofemoral pain (PFP; n = 61; mean age, 27 +/- 9 years) were enrolled. Patients with PFP received standard multimodal treatment 3 times a week for 6 weeks. Patients not responding to multimodal treatment were then classified into 1 of 3 subgroups (strong, weak and tight, and weak and pronated foot) using 6 simple clinical tests. They were subsequently administered 6 further weeks of targeted intervention, designed according to subgroup characteristics. Visual analog scale (VAS), perception of recovery scale (PRS), 5-Level European Quality 5 Dimensions (EQ-5D-5L), and self-reported version of the Leeds Assessment of Neuropathic Symptoms and Signs scale (S-LANSS) were used to assess pain, knee function, and quality of life before and after the interventions. Results: In total, 34% (n = 21) of patients demonstrated recovery after multimodal treatment. However, over 70% (n = 29/40) of nonresponders demonstrated recovery after targeted treatment. The VAS, PRS, S-LANSS, and EQ-5D-5L scores improved significantly after targeted intervention compared with after multimodal treatment (P < 0.001). The VAS score at rest was significantly lower in the "weak and pronated foot" and the "weak and tight" subgroups (P = 0.011 and P = 0.008, respectively). Posttreatment pain intensity on activity was significantly lower in the "strong" subgroup (P = 0.006). Conclusion: Targeted treatment designed according to subgroup characteristics improves clinical outcomes in patients unresponsive to multimodal treatment.